NDC 50090-7357-00 - Bisoprolol Fumarate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7357
- Requested NDC
- 50090-7357-00
- Package NDCs from labels
- 50090-7357-0, 50090-7357-2, 50090-7357-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bisoprolol Fumarate and Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2026-03-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7357-0 | Bisoprolol Fumarate and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 6 | |
| 50090-7357-2 | Bisoprolol Fumarate and Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-7357 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 4 | Current NDC, 2 package rows | 20241023_9271a2d7-be94-4e38-9f71-41e8d55e10bc.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7357-0 | EA - Each | 50090-7357 | 21da657a-4571-48f4-a7f7-18a0b4e56ab3 | 1 | 2024-11-05 |
| 50090-7357-2 | EA - Each | 50090-7357 | bd5f6002-c0c5-46c2-bb49-379fcb7379e0 | 1 | 2024-11-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | bdd4348d-928d-ef0b-e053-2a95a90aadb4 | 2026-02-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Perfect Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | SKIN PERFECT MEDICAL | 4b47e7cb-17d6-6a7c-e063-6294a90abbea | 2026-02-20 | Warnings | 15FIX9V2JP |
| Calamine | FERRIC OXIDE RED | Perrigo Direct, Inc | 256bd1d4-fd50-408f-9aee-84f218bb4971 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXIND HCL | Perrigo Direct, Inc | 54a20ec9-ab86-4410-af94-e04393e9d4b3 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Meijer, Inc. | 6b369ef2-fd54-4931-a9eb-0fb42834c2ef | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | A-S Medication Solutions | 7d4ee5ec-5b68-453b-8d6e-214457a58159 | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | A-S Medication Solutions | 62e8c093-cd8e-4342-aadb-209c7e6699c8 | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Allay Skin Solutions Protect Nourish Mineral Sunscreen SPF 42 | TITANIUM DIOXIDE, ZINC OXIDE | ALLAY SKIN SOLUTIONS LLC | 425bf1d7-f2cf-4237-9047-dd53054acd1c | 2026-02-18 | Warnings | 15FIX9V2JP |
| Calamine | FERRIC OXIDE RED | Target Corporation | d4ee05c8-ae62-45df-8783-1ed57fa030ec | 2026-02-18 | Warnings, Adverse reactions | 1K09F3G675 |
| Hermes Plein Air-Baume de Teint Perfecteur Naturel-Enhancing Complexion Balm 85 TAMARIN | TITANIUM DIOXIDE | S.A. COMPTOIR NOUVEAU DE LA PARFUMERIE | dacff3dc-49d7-6416-e053-2a95a90a85c6 | 2026-02-18 | Warnings | 15FIX9V2JP |
| Mitochondria Pro | ARALIA QUINQUEFOLIA, ARNICA MONTANA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, ASCORBICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CALCAREA CARBONICA, CITRICUM ACIDUM, CUPRUM METALLICUM, CYSTEINUM, FERRUM METALLICUM, IODIUM, LEVOTHYROXINUM, MAGNESIUM GLUCONICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM ACETICUM, NADIDUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SELENIUM METALLICUM, SULPHUR, THIAMINUM HYDROCHLORICUM, UBIDECARENONUM, ZINCUM METALLICUM, | Energique, Inc. | 2f365207-b730-428d-9465-8853e86e79ff | 2026-02-18 | Warnings | ETJ7Z6XBU4 |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Apotex Corp. | bd6c3495-ec70-908b-482a-a979506659e9 | 2026-02-17 | Warnings, Adverse reactions | 0J48LPH2TH |
| BIO COM 25 ACIDITY | NAT PHOS, NAT SULPH, SILICEA | BM Private Limited | 3b3c3455-b321-071d-e063-6394a90a0160 | 2026-02-17 | Warnings | ETJ7Z6XBU4 |
| CINA | AMBROSIA, CINA, CUCURBITA CIT, CUCURBITA PEP, INDIGO, SANTONINE, SILICEA | BM PRIVATE LIMITED | 3b3c0874-90b5-deda-e063-6394a90a7802 | 2026-02-15 | Warnings | ETJ7Z6XBU4 |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | dc9512cf-db66-40e9-afcb-1d6a722772e8 | 2026-02-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Acne/Pimple Control | CALENDULA OFFICINALIS FLOWERING TOP AND SILICON DIOXIDE | Forces of Nature | e871e46e-463e-49ec-a2af-5aa98548ee12 | 2026-02-13 | Warnings | ETJ7Z6XBU4 |
| Calamine | FERRIC OXIDE RED | Topco Associates LLC | 2b32e720-ac71-4d60-bc06-e28a00f8a450 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Topco Associates LLC | 15d1ae3f-509c-4e6b-8f0c-cf9265680358 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
| Diovan HCT | VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | d76a0419-05ee-437e-884c-65807aea9569 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Fuligo | CIMICIFUGA, DROSERA, FORMICA RUFA, FULIGO, INULA HEL., KALI MUR, LAPIS ALBUS, SILICEA | BM Private Limited | 3b27225f-4587-d915-e063-6294a90a7225 | 2026-02-12 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.